| Biomarker ID | 569 |
| PMID | 21088161 |
| Year | 2010 |
| Biomarker | D-Dimer |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Blood |
| Subjects | Humans |
| Regulation | Upregulated in Progressive Disease |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 12.07 |
| Effect on Pathways | NA |
| Experiment | progressive disease (PD) Vs nonprogressive disease (non-PD) |
| Type of Biomarker | Prognostic |
| Cohort | 28 patients with refractory castration-resistant prostate cancer |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.024 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | The paper compared PSA, CTC and D-dimers are biomarkers for progressive disease, D-dimers were a more significant predictor of progressive disease. |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |